JSS Medical Research Inc

JSS Medical Research Inc is a full-service Contract Research Organization (CRO) that specializes in clinical research, providing comprehensive services for all phases of clinical trials to various global clients. Founded in 1985 in Canada, JSS Medical Research Inc operates as a Contract Research Organization (CRO) offering clinical research services. The company does not operate as a subsidiary of any parent company. It has undergone no notable pivots in its business strategy since its inception.

JSS Medical Research has offices in multiple locations globally and was co-founded by individuals with experience in the clinical research field. In May 2023, JSS Medical Research was acquired by Genesis Biotechnology Group, LLC, which aims to leverage the acquisition to enhance its operations and expand into global markets. JSS Medical Research offers a comprehensive range of clinical research services as a full-service Contract Research Organization (CRO), specializing in all phases of clinical trials, including Phase I-IV. Their core product offerings encompass clinical trial management, study design, biostatistics, medical writing, and health economics and outcomes research (HEOR) consulting.

The company serves a diverse client base, including global pharmaceutical, biotechnology, medical device, and nutraceutical companies, providing tailored solutions to meet specific research needs. With a presence in over 21 countries, including established markets in North America and Europe, as well as emerging markets in Latin America and Asia, JSS Medical Research is capable of managing high-volume studies across various therapeutic areas such as oncology, immunology, and infectious diseases. The company’s adaptable project management approach and commitment to scientific excellence enable clients to navigate the complexities of clinical development efficiently. JSS Medical Research generates revenue through a structured model that includes partnerships and B2B transactions with clients.

The firm enters into contracts for clinical trial services, providing solutions tailored to the specific needs of pharmaceutical and biotech clients. Clients typically engage JSS Medical Research for comprehensive services that may include study design, trial management, and regulatory submissions, reflecting a collaborative relationship throughout the development process. The diverse service offerings are associated with various pricing structures based on the scope and complexity of each project, resulting in revenue streams from ongoing contracts as well as project-based engagements that focus on delivering high-quality results in compliance with global regulatory standards. Following the acquisition by Genesis Biotechnology Group, LLC in May 2023, JSS Medical Research plans to utilize its new resources to scale operations and further expand into global markets.

The acquisition is expected to facilitate a broader reach and enhance the company’s capabilities in clinical research. Specific details on upcoming new products and their release dates have not yet been disclosed. The company is strategically positioned to explore additional international markets, enhancing its footprint in the clinical research sector.